BeStock  
Stocks › Biotechnology › INSM

Insmed INSM

US equityMarket cap rank #511Biotechnology
$110.61 −$3.53 (-3.09%)
Market open · Oct 1, 11:50 am ET · After hours $115.68 +1.35%
Open$114.51
Prev close$114.14
Day range$109.71 – $116.18
Volume708.2K
Market cap$24.16B
P/E (TTM)–
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings-27.7x
CheapRich

Near the bottom of its 5-year range · 8th percentile, 5-year average -12.0x

Price / book32.9x
CheapRich

Above its usual level · 66th percentile, 5-year average 29.3x

#5183 of 5307 stocks by PB (1 = cheapest)

Price / sales21.9x
CheapRich

Around its usual level · 53rd percentile, 5-year average 29.4x

#4688 of 5144 stocks by PS (1 = cheapest)

Morningstar fair value estimate

Fair value$135.75
Price vs. fair value-18.5%Trading below the estimate
Star rating★★★☆☆
Economic moatNone
UncertaintyHigh
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB 32.90 – 29.31 66% (pricier than usual) #5183 of 5307 (1 = cheapest)
PE -27.70 -169.59 -11.95 8% (cheaper than usual) –
PS 21.91 10.69 29.45 53% (pricier than usual) #4688 of 5144 (1 = cheapest)

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Morningstar view

Star rating★★★
Fair value estimate$135.75
Economic moatNone
UncertaintyHigh

Discussion

No comments yet — be the first to weigh in on INSM.

Leave a comment

Scroll to Top